In Depth 13 Dec 2024
Is China the future of biotech?
…2015 to less than 100 days in 2023. China investing in R&D and talent China’s biopharma research and development (R&D) spending has grown at an unprecedented rate. By 2023, China’s…
Search Results for: China
In Depth 19 Jul 2023
Genetic engineering giants: is China poised to lead the way?
…in China,” said Fiona Gao, founding partner of Chinsiders. Gao also said that gene editing has been listed as a key strategic goal for China: “Gene editing has been listed…
In Depth 11 Feb 2020
Why European Biotechs Should Look to China for Investment
…bit different because you can bring things into China, potentially with no China data, which is a completely new thing,” commented co-panellist Greg Scott, CEO and founder of ChinaBio, a…
Best in Biotech 30 Apr 2024
5 private biotech companies in China you should know about
…that have raised major rounds in China. China’s biotech industry has undergone a momentous shift in recent decades, evolving from a generics-focused space to a thriving biotech hub. This is…
ADVERTISEMENT
News and Trends 15 Apr 2025
The AI race in biotech: Is Europe falling behind the US and China?
…US and China lead the way In October 2024, Jensen Huang, the CEO of AI chipmaker Nvidia, commented that the European Union (EU) lags far behind the U.S. and China…
News and Trends 20 Jul 2023
Endometrial cancer drug receives breakthrough therapy designation in China
HUTCHMED (China) Limited has announced that the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to the combination of fruquintinib and…
News and Trends 4 Aug 2022
Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence
Sanofi and Innovent Biologics are to collaborate on providing medicines to patients in China with difficult-to-treat cancers. Innovent is a biopharmaceutical company with clinical development capabilities and a broad commercial…
Opinion 30 Sep 2019
Can European Biotech Companies Afford Not to Work with China?
In the current trade standoff between the US and China, Europe has a golden opportunity to gain a competitive advantage. At every healthcare conference I’ve been to recently in the…
News and Trends 14 Nov 2022
Nuance Pharma’s RSV vaccine cleared for trial in China
Nuance Pharma says China’s Center for Drug Evaluation (CDE) has approved its investigational new drug (IND) application supporting its pivotal phase III clinical trial of MVA-BN RSV vaccine against respiratory…
News and Trends 17 Feb 2023
Report: China leads the way with phase 1 studies
…China, Australia, South Korea, Japan and India. Of all the five locations put together, China occupies the major share (more than 80%) of phase 1 trials in all the top…
News and Trends 14 Nov 2022
HUTCHMED announces positive gastric cancer study results in China
…patients based on the FRUTIGA trial.” HUTCHMED retains all commercial rights to fruquintinib outside of China. In China, where fruquintinib is marketed under the brand name ELUNATE, HUTCHMED is partnered…
News and Trends 30 Mar 2016
German Biotech targets China for Lung Cancer Liquid Biopsies
…the completion of the ADMIT trial. In China, the test was approved in 2014, after a licensing deal with BioChain, a manufacturer in the Life Sciences field. China quickly became…
